ROBERT BERKE: Open Payments
NPI 1720057599 · WESTFIELD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 36 payments from 19 companies in 2025. Trend: 2023 $795 · 2024 $568 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $94 |
| Novo Nordisk Inc | 4 | $84 |
| Lilly USA, LLC | 4 | $83 |
| Sumitomo Pharma America, Inc. | 3 | $73 |
| Exact Sciences Corporation | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Amgen Inc. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $34 |
Products named: Kerendia, GEMTESA, JARDIANCE, Cologuard Collection Kit, Wegovy, KEVEYIS, CAPLYTA, OTEZLA.
Industry payments across NY — which companies pay providers there.
